Literature DB >> 32118585

Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.

Xia Liu, Daniel F Hoft, Guangyong Peng.   

Abstract

The functional state of the preexisting T cells in the tumor microenvironment is a key determinant for effective antitumor immunity and immunotherapy. Increasing evidence suggests that immunosenescence is an important state of T cell dysfunction that is distinct from exhaustion, a key strategy used by malignant tumors to evade immune surveillance and sustain the suppressive tumor microenvironment. Here, we discuss the phenotypic and functional characteristics of senescent T cells and their role in human cancers. We also explore the possible mechanisms and signaling pathways responsible for induction of T cell senescence by malignant tumors, and then discuss potential strategies to prevent and/or reverse senescence in tumor-specific T cells. A better understanding of these critical issues should provide novel strategies to enhance cancer immunotherapy.

Entities:  

Mesh:

Year:  2020        PMID: 32118585      PMCID: PMC7269563          DOI: 10.1172/JCI133679

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  175 in total

Review 1.  Potential role of immunosenescence in cancer development.

Authors:  Tamas Fulop; Rami Kotb; Carl F Fortin; Graham Pawelec; Flavia de Angelis; Anis Larbi
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

Review 2.  Telomeres and immunological diseases of aging.

Authors:  Nicolas P Andrews; Hiroshi Fujii; Jörg J Goronzy; Cornelia M Weyand
Journal:  Gerontology       Date:  2009-12-17       Impact factor: 5.140

Review 3.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

4.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation.

Authors:  Simona Parrinello; Jean-Philippe Coppe; Ana Krtolica; Judith Campisi
Journal:  J Cell Sci       Date:  2005-01-18       Impact factor: 5.285

5.  Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.

Authors:  K Imamura; T Ogura; A Kishimoto; M Kaminishi; H Esumi
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

6.  The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis.

Authors:  Jiyong Liang; Shan H Shao; Zhi-Xiang Xu; Bryan Hennessy; Zhiyong Ding; Michelle Larrea; Seiji Kondo; Dan J Dumont; Jordan U Gutterman; Cheryl L Walker; Joyce M Slingerland; Gordon B Mills
Journal:  Nat Cell Biol       Date:  2007-01-21       Impact factor: 28.824

7.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

8.  Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.

Authors:  Guohong Song; Xiaoli Wang; Jun Jia; Yanhua Yuan; Fengling Wan; Xinna Zhou; Huabing Yang; Jun Ren; Jiezhun Gu; Herbert Kim Lyerly
Journal:  Cancer Immunol Immunother       Date:  2013-04-21       Impact factor: 6.968

Review 9.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

10.  Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Authors:  Marta Szajnik; Malgorzata Czystowska; Miroslaw J Szczepanski; Magis Mandapathil; Theresa L Whiteside
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

View more
  17 in total

Review 1.  Tumor microenvironment metabolites directing T cell differentiation and function.

Authors:  Xia Liu; Daniel F Hoft; Guangyong Peng
Journal:  Trends Immunol       Date:  2021-12-29       Impact factor: 16.687

2.  Microenvironment immune reconstitution patterns correlate with outcomes after autologous transplant in multiple myeloma.

Authors:  Harsh Parmar; Morie Gertz; Emilie Ingrid Anderson; Shaji Kumar; Taxiarchis V Kourelis
Journal:  Blood Adv       Date:  2021-04-13

3.  Melanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases.

Authors:  Dimitri G Trembath; Anastasia Ivanova; Michal T Krauze; John M Kirkwood; Nana Nikolaishvilli-Feinberg; Stergios J Moschos
Journal:  Melanoma Res       Date:  2021-06-01       Impact factor: 3.199

Review 4.  Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword.

Authors:  Anthony M Battram; Mireia Bachiller; Beatriz Martín-Antonio
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

Review 5.  Cancer immunotherapy comes of age and looks for maturity.

Authors:  Amanda Finck; Saar I Gill; Carl H June
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

Review 6.  Counteracting CAR T cell dysfunction.

Authors:  Mansour Poorebrahim; Jeroen Melief; Yago Pico de Coaña; Stina L Wickström; Angel Cid-Arregui; Rolf Kiessling
Journal:  Oncogene       Date:  2021-01-14       Impact factor: 9.867

7.  TNF Family-Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma.

Authors:  Huihuang Li; Siyuan Liu; Chenxuan Li; Zicheng Xiao; Jiao Hu; Cheng Zhao
Journal:  Front Cell Dev Biol       Date:  2022-01-31

8.  NK and NKT cells have distinct properties and functions in cancer.

Authors:  Xia Liu; Lingyun Li; Fusheng Si; Lan Huang; Yangjing Zhao; Chenchen Zhang; Daniel F Hoft; Guangyong Peng
Journal:  Oncogene       Date:  2021-06-12       Impact factor: 9.867

Review 9.  Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.

Authors:  Anindita Chakrabarty; Shayantani Chakraborty; Ranjini Bhattacharya; Goutam Chowdhury
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

Review 10.  Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses.

Authors:  Maximilian Rentschler; Heidi Braumüller; Priscilla S Briquez; Thomas Wieder
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.